BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20665677)

  • 41. Zinc supplementation inhibits the increase in osteoclastogenesis and decrease in osteoblastogenesis in streptozotocin-induced diabetic rats.
    Iitsuka N; Hie M; Tsukamoto I
    Eur J Pharmacol; 2013 Aug; 714(1-3):41-7. PubMed ID: 23735664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Total coumarins from fruits of Cnidium monnieri inhibit formation and differentiation of multinucleated osteoclasts of rats.
    Qin LP; Zhang QY; Tian YP; Zheng HC; Haung M; Huang BK
    Acta Pharmacol Sin; 2003 Feb; 24(2):181-6. PubMed ID: 12546728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medicarpin inhibits osteoclastogenesis and has nonestrogenic bone conserving effect in ovariectomized mice.
    Tyagi AM; Gautam AK; Kumar A; Srivastava K; Bhargavan B; Trivedi R; Saravanan S; Yadav DK; Singh N; Pollet C; Brazier M; Mentaverri R; Maurya R; Chattopadhyay N; Goel A; Singh D
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):101-9. PubMed ID: 20570709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Osteocalcin promotes differentiation of osteoclast progenitors from murine long-term bone marrow cultures.
    Liggett WH; Lian JB; Greenberger JS; Glowacki J
    J Cell Biochem; 1994 Jun; 55(2):190-9. PubMed ID: 8089194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption.
    Jilka RL; Takahashi K; Munshi M; Williams DC; Roberson PK; Manolagas SC
    J Clin Invest; 1998 May; 101(9):1942-50. PubMed ID: 9576759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sol-gel bioactive glasses support both osteoblast and osteoclast formation from human bone marrow cells.
    Karpov M; Laczka M; Leboy PS; Osyczka AM
    J Biomed Mater Res A; 2008 Mar; 84(3):718-26. PubMed ID: 17635026
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of colony-stimulating factors in osteoclast development.
    Takahashi N; Udagawa N; Akatsu T; Tanaka H; Shionome M; Suda T
    J Bone Miner Res; 1991 Sep; 6(9):977-85. PubMed ID: 1724107
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced expression of interleukin-11 in bone marrow stromal cells of senescence-accelerated mice (SAMP6): relationship to osteopenia with enhanced adipogenesis.
    Kodama Y; Takeuchi Y; Suzawa M; Fukumoto S; Murayama H; Yamato H; Fujita T; Kurokawa T; Matsumoto T
    J Bone Miner Res; 1998 Sep; 13(9):1370-7. PubMed ID: 9738508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of low-level laser therapy on proliferation and differentiation of murine bone marrow cells into osteoblasts and osteoclasts.
    Bouvet-Gerbettaz S; Merigo E; Rocca JP; Carle GF; Rochet N
    Lasers Surg Med; 2009 Apr; 41(4):291-7. PubMed ID: 19347941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Osteoclast differentiation in cocultures of a clonal chondrogenic cell line and mouse bone marrow cells.
    Taylor LM; Turksen K; Aubin JE; Heersche JN
    Endocrinology; 1993 Nov; 133(5):2292-300. PubMed ID: 7691585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
    J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro.
    Okazaki R; Toriumi M; Fukumoto S; Miyamoto M; Fujita T; Tanaka K; Takeuchi Y
    Endocrinology; 1999 Nov; 140(11):5060-5. PubMed ID: 10537132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone substitute materials supplemented with prolyl hydroxylase inhibitors decrease osteoclastogenesis in vitro.
    Vinzenz P; Schröckmair S; Gruber R; Agis H
    J Biomed Mater Res B Appl Biomater; 2015 Aug; 103(6):1198-203. PubMed ID: 25312707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
    Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W
    Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cadmium stimulates the osteoclastic differentiation of RAW264.7 cells in presence of osteoblasts.
    Chen X; Zhu G; Jin T; Zhou Z; Gu S; Qiu J; Xiao H
    Biol Trace Elem Res; 2012 Jun; 146(3):349-53. PubMed ID: 22076734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bone morphogenetic proteins 2, 5, and 6 in combination stimulate osteoblasts but not osteoclasts in vitro.
    Wutzl A; Rauner M; Seemann R; Millesi W; Krepler P; Pietschmann P; Ewers R
    J Orthop Res; 2010 Nov; 28(11):1431-9. PubMed ID: 20872578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease.
    Mucci JM; Suqueli GarcĂ­a F; de Francesco PN; Ceci R; Di Genaro S; Fossati CA; Delpino MV; Rozenfeld PA
    Gene; 2013 Dec; 532(2):186-91. PubMed ID: 24076352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rheological characterization of cellulosic and alginate polymers.
    Duggirala S; Deluca PP
    PDA J Pharm Sci Technol; 1996; 50(5):290-6. PubMed ID: 8973114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.